We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NKTR market cap is 165.27M. The company's latest EPS is USD -1.5034 and P/E is -0.63.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 23.63M | 22.02M | 21.59M | 20.5M | 24.14M |
Operating Income | -154.66M | 9.97M | -134.71M | -50.6M | -14.31M |
Net Income | -59.05M | -59.69M | -137.02M | -51.12M | -45.84M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 114.62M | 152.92M | 101.91M | 92.06M | 90.12M |
Operating Income | -440.04M | -379.92M | -446.1M | -313.73M | -263.68M |
Net Income | -440.67M | -444.44M | -523.84M | -368.2M | -276.06M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 781.01M | 710.6M | 561.74M | 494.28M | 442.24M |
Total Liabilities | 368.78M | 343.96M | 320.88M | 297.32M | 282.88M |
Total Equity | 412.22M | 366.64M | 240.87M | 196.96M | 159.37M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.98B | 1.54B | 1.12B | 710.6M | 398.03M |
Total Liabilities | 571.97M | 461.47M | 437.68M | 343.96M | 267.05M |
Total Equity | 1.41B | 1.08B | 679.51M | 366.64M | 130.99M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -246.3M | -304.01M | -51.92M | -103.44M | -145.56M |
Investing | 325.82M | 365.84M | 40.6M | 65.77M | 122.18M |
Financing | 1.41M | 1.51M | N/A | 18k | 18k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -328.68M | -313.29M | -412.66M | -304.01M | -192.61M |
Investing | 206.89M | 496.21M | 202.78M | 365.84M | 139.56M |
Financing | 23.36M | -80.35M | 36.24M | 1.51M | 30k |
Market Cap | 165.27M |
Price to Earnings Ratio | -0.63 |
Price to Sales Ratio | 1.92 |
Price to Cash Ratio | 4.89 |
Price to Book Ratio | 1.32 |
Dividend Yield | - |
Shares Outstanding | 183.62M |
Average Volume (1 week) | 1.19M |
Average Volume (1 Month) | 2.57M |
52 Week Change | 16.29% |
52 Week High | 1.12 |
52 Week Low | 0.4126 |
Spread (Intraday) | 0.02 (2.34%) |
Company Name | Nektar Therapeutics |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.nektar.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions